Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service?
Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
Expression analysis of human TL1A on Raji/Membrane-Bound Human TL1A Stable Cell Line by FACS.
Cell surface staining was performed on Raji/Membrane-Bound Human TL1A Stable Cell Line or negative control cell using anti-human TL1A antibody followed by staining with PE anti-human IgG Fc antibody.
Expression analysis of human TL1A on HEK293/Membrane-Bound Human TL1A Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Membrane-Bound Human TL1A Stable Cell Line or negative control cell using anti-human TL1A antibody followed by staining with PE anti-human IgG Fc antibody.
Human TL1A Protein, Fc Tag (Cat. No. TLA-H5263) immobilized on CM5 Chip can bind Human DcR3, Fc Tag (Cat. No. TNB-H5255) with an affinity constant of 0.621 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
RG-6631 | RG6631; RG-6631 | Phase 3 Clinical | F. Hoffmann-La Roche Ltd | Colitis, Ulcerative | Details |
Tulisokibart | PRA-023; MK-7240; PRA023 | Phase 3 Clinical | Prometheus Biosciences Inc, Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Colitis, Ulcerative; Scleroderma, Diffuse; Crohn Disease | Details |
Duvakitug | TEV574; TEV-574; TEV-48574; TEV-574; TEV574; SAR447189; SAR-447189 | Phase 2 Clinical | Teva Pharmaceutical Industries Ltd | Asthma; Colitis, Ulcerative; Crohn Disease | Details |
XmAb-942 | XmAb942; XmAb-942 | Phase 2 Clinical | Xencor Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative | Details |
RVT-3101 | PF-06480605; PF 6480605; RVT-3101 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease | Details |
PF-07261271 | PF-07261271 | Phase 1 Clinical | Pfizer Inc | Inflammatory Bowel Diseases | Details |
SPY-002 | SPY002-091; SPY002 072; SPY-002; PR-010 | Phase 1 Clinical | Paragon Therapeutics Inc | Details | |
SPY002-072 | SPY002-072 | Phase 1 Clinical | Spyre Therapeutics Inc, Novotech (Australia) Pty Ltd | Details | |
BCD-261 | BCD-261 | Phase 1 Clinical | BIOCAD JSC | Colitis, Ulcerative; Crohn Disease | Details |
Next-generation anti-TL1A antibody(Telavant) | Phase 1 Clinical | Telavant Inc | Fibrosis; Inflammation | Details |
This web search service is supported by Google Inc.